Inflammatory Bowel Disease (IBD)
95
33
38
25
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.3%
5 terminated out of 95 trials
83.3%
-3.2% vs benchmark
4%
4 trials in Phase 3/4
20%
5 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (95)
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland
Study of DISC-0974-201 in Participants With IBD and Anemia
Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE) in Participants With Inflammatory Bowel Disease (IBD)
A Phase 1 Study of PVT401 in Healthy Subjects
Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
Elemental 028 Extra Case Studies
A Pilot Study on the Efficacy and Safety of a Novel Synbiotic Formula (SGR11) in Patients With Inflammatory Bowel Disease (IBD)
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Diagnosis of Inflammatory Bowel Disease
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
Setting up a Cohort of Patients With Inflammatory Bowel Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Personalized Exercise Coaching to Improve Quality of Life in Pediatric IBD
Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway
Impact of Obesity on Response to Therapy and Clinical Outcom in Patients With Inflammatory Bowel Disease
A Clinical Study on The Use of DL-endopeptidase-producing Probiotics as an Adjunctive Therapy for Inflammatory Bowel Disease.